Carcinoma, Transitional Cell 
Welcome,         Profile    Billing    Logout  

2 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Carcinoma, Transitional Cell
NCT03133390: Atezolizumab With or Without Bevacizumab in Cisplatin-ineligible Patients

Active, not recruiting
2
2
US
Atezolizumab 1200 mg, Tecentriq, Bevacizumab 15 mg/kg IV, Avastin
New York University School of Medicine
Urothelial Carcinoma
07/19
01/20
NCT02701023: Compassionate Use of MitoGel in Upper Tract Urothelial Carcinoma

No Longer Available
N/A
US
MitoGel
Jonsson Comprehensive Cancer Center, UroGen Pharma Ltd.
Urothelial Carcinoma Ureteral Location
 
 

Download Options